Precision Profiling

...predictive single cell response.

Our technology and applications enable improved targeting of complex treatments to the cancer patients who need them most. Scientific leaders at Yale and Caltech developed the IsoPlexis precision engineering platform to detect the full (omic) set of functions from thousands of single patient cells. This unprecedented quantity and quality of data from single cells is providing breakthrough clinical biomarker insights into highly urgent areas of oncology today.

Precision engineering platform developed at Yale and Caltech

The IsoPlexis IsoCode readout captures the omic end function from thousands of single cells in parallel to better understand complex patient response. The IsoCode chip, recognized in the literature as the SCBC, has been well validated in various immune and cancer detection applications, and has been making breakthroughs with UCLA, Memorial Sloan Kettering, and more.

Our Technology

The IsoCode chip (SCBC) captures the omic end function from thousands of single cells in parallel to better understand complex patient response.

The IsoLight automation system – available for early access later this year – provides a simple, integrated solution for running IsoCode assays in the lab.

The IsoSpeak software performs image processing, computation, and advanced informatics to compare single-cell function responses across patient groups.